ANDA 75306, held by Actavis Elizabeth. Isosorbide Mononitrate.
As of Nov 16, 2026, ANDA 75306 (Isosorbide Mononitrate), held by Actavis Elizabeth, was first approved by FDA on Dec 31, 1998, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 31, 1998 | Original application | Approved | None posted |
| Isosorbide Mononitrate30MG · tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
| Isosorbide Mononitrate60MG · tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
| Nov 2, 2001 | Supplement 4Manufacturing | Approved | None posted |
| Mar 19, 2001 | Supplement 3Manufacturing | Approved | None posted |
| Aug 31, 1999 | Supplement 1Manufacturing | Approved | None posted |
| Jun 1, 1999 | Supplement 2Labeling | Approved | None posted |
| Dec 31, 1998 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters